BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernandes C, Martins C, Fonseca A, Nunes R, Matos MJ, Silva R, Garrido J, Sarmento B, Remião F, Otero-Espinar FJ, Uriarte E, Borges F. PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor. ACS Appl Mater Interfaces 2018;10:39557-69. [PMID: 30352150 DOI: 10.1021/acsami.8b17224] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Mellado M, Mella J, González C, Viña D, Uriarte E, Matos MJ. 3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter? Bioorganic Chemistry 2020;101:103964. [DOI: 10.1016/j.bioorg.2020.103964] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Silva B, Silva R, Fernandes C, Guedes de Pinho P, Remião F. Enantioselectivity on the absorption of methylone and pentedrone using Caco-2 cell line: Development and validation of an UHPLC method for cathinones quantification. Toxicol Appl Pharmacol 2020;395:114970. [PMID: 32234388 DOI: 10.1016/j.taap.2020.114970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Guo S, Liang Y, Liu L, Yin M, Wang A, Sun K, Li Y, Shi Y. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics. J Nanobiotechnology 2021;19:32. [PMID: 33499885 DOI: 10.1186/s12951-021-00770-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Nguyen TT, Dung Nguyen TT, Vo TK, Tran NM, Nguyen MK, Van Vo T, Van Vo G. Nanotechnology-based drug delivery for central nervous system disorders. Biomed Pharmacother 2021;143:112117. [PMID: 34479020 DOI: 10.1016/j.biopha.2021.112117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pinto M, Fernandes C, Martins E, Silva R, Benfeito S, Cagide F, Mendes RF, Almeida Paz FA, Garrido J, Remião F, Borges F. Boosting Drug Discovery for Parkinson's: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. Pharmaceutics 2019;11:E331. [PMID: 31336891 DOI: 10.3390/pharmaceutics11070331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mesiti F, Maruca A, Silva V, Rocca R, Fernandes C, Remião F, Uriarte E, Alcaro S, Gaspar A, Borges F. 4-Oxoquinolines and monoamine oxidase: When tautomerism matters. Eur J Med Chem 2021;213:113183. [PMID: 33493825 DOI: 10.1016/j.ejmech.2021.113183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hu F, Yan T, Guo W, Liu Q, Han MH, Liu C, Liu Y, Zheng W, You F, Yang Y, Zhang W, Ma X. Multiple targeting strategies achieve novel protein drug delivery into proapoptosis lung cancer cells by precisely inhibiting survivin. Nanoscale 2020;12:10623-38. [DOI: 10.1039/d0nr01352h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gil-Martins E, Barbosa DJ, Silva V, Remião F, Silva R. Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders. Pharmacol Ther 2020;213:107554. [PMID: 32320731 DOI: 10.1016/j.pharmthera.2020.107554] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
9 Wang P, Wang Y, Li P, Chen C, Ma S, Zhao L, He H, Yin T, Zhang Y, Tang X, Gou J. Oral delivery of polyester nanoparticles for brain-targeting: Challenges and opportunities. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.07.034] [Reference Citation Analysis]
10 Paolino D, Tudose A, Celia C, Di Marzio L, Cilurzo F, Mircioiu C. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals. Materials (Basel) 2019;12:E693. [PMID: 30813650 DOI: 10.3390/ma12050693] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
11 Mukherjee S, Madamsetty VS, Bhattacharya D, Roy Chowdhury S, Paul MK, Mukherjee A. Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics. Adv Funct Mater 2020;30:2003054. [DOI: 10.1002/adfm.202003054] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
12 Inphonlek S, Sunintaboon P, Léonard M, Durand A. Chitosan/carboxymethylcellulose-stabilized poly(lactide-co-glycolide) particles as bio-based drug delivery carriers. Carbohydr Polym 2020;242:116417. [PMID: 32564826 DOI: 10.1016/j.carbpol.2020.116417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Benfeito S, Fernandes C, Vilar S, Remião F, Uriarte E, Borges F. Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer's Disease Pathophysiological Hallmarks. Molecules 2020;25:E276. [PMID: 31936622 DOI: 10.3390/molecules25020276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Matos MJ, Uriarte E, Santana L. 3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade. Molecules 2021;26:6755. [PMID: 34771164 DOI: 10.3390/molecules26216755] [Reference Citation Analysis]
15 Barbosa JS, Pinto M, Barreiro S, Fernandes C, Mendes RF, Lavrador P, Gaspar VM, Mano JF, Borges F, Remião F, Braga SS, Paz FAA. Coordination Compounds As Multi-Delivery Systems for Osteoporosis. ACS Appl Mater Interfaces 2021;13:35469-83. [PMID: 34284573 DOI: 10.1021/acsami.1c09121] [Reference Citation Analysis]
16 Chavarria D, Fernandes C, Aguiar B, Silva T, Garrido J, Remião F, Oliveira PJ, Uriarte E, Borges F. Insights into the Discovery of Novel Neuroprotective Agents: A Comparative Study between Sulfanylcinnamic Acid Derivatives and Related Phenolic Analogues. Molecules 2019;24:E4405. [PMID: 31810314 DOI: 10.3390/molecules24234405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chavarria D, Fernandes C, Silva V, Silva C, Gil-Martins E, Soares P, Silva T, Silva R, Remião F, Oliveira PJ, Borges F. Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies. Eur J Med Chem 2020;185:111770. [PMID: 31711793 DOI: 10.1016/j.ejmech.2019.111770] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
18 Mesiti F, Gaspar A, Chavarria D, Maruca A, Rocca R, Gil Martins E, Barreiro S, Silva R, Fernandes C, Gul S, Keminer O, Alcaro S, Borges F. Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas? J Med Chem 2021;64:11169-82. [PMID: 34269579 DOI: 10.1021/acs.jmedchem.1c00510] [Reference Citation Analysis]
19 Sato Y, Oyobe N, Ogawa T, Suzuki S, Aoyama H, Nakamura T, Fujioka H, Shuto S, Arisawa M. Design, Synthesis, and Monoamine Oxidase Inhibitory Activity of (+)-Cinchonaminone and Its Simplified Derivatives. ACS Med Chem Lett 2021;12:1464-9. [PMID: 34531955 DOI: 10.1021/acsmedchemlett.1c00310] [Reference Citation Analysis]
20 Cayero-Otero MD, Gomes MJ, Martins C, Álvarez-Fuentes J, Fernández-Arévalo M, Sarmento B, Martín-Banderas L. In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles. Expert Opin Drug Deliv 2019;16:1413-27. [PMID: 31694417 DOI: 10.1080/17425247.2019.1690452] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
21 Hu F, Zhang R, Guo W, Yan T, He X, Hu F, Ren F, Ma X, Lei J, Zheng W. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer. Mol Pharm 2021;18:2161-73. [PMID: 32515968 DOI: 10.1021/acs.molpharmaceut.0c00321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
22 Hu F, Deng C, Zhou Y, Liu Y, Zhang T, Zhang P, Zhao Z, Miao H, Zheng W, Zhang W, Wang M, Ma X. Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment‐mediated protein nanocages for enhancing cancer biotherapy. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10290] [Reference Citation Analysis]
23 Reis J, Fernandes C, Salem H, Maia M, Tomé C, Benfeito S, Teixeira J, Oliveira PJ, Uriarte E, Ortuso F, Alcaro S, Bagetta D, Cagide F, Borges F. Design and synthesis of chromone-based monoamine oxidase B inhibitors with improved drug-like properties. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114507] [Reference Citation Analysis]